​The ABPI is seeking clarification from the Department of Health on the future of the Earlier Access Scheme.


The aim of the scheme, which sets it apart from other initiatives, is to provide access for high-need patients to clearly defined high-benefit medicines that are not yet formally licensed. We understand this is on hold during the ‘pause’, not rejected by ministers.

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.